| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Gastrointestinal Microbiome | 33 | 2020 | 1961 | 4.21 | Why? |
| Helicobacter Infections | 9 | 2019 | 216 | 2.96 | Why? |
| Helicobacter pylori | 9 | 2019 | 262 | 2.45 | Why? |
| Irritable Bowel Syndrome | 8 | 2019 | 175 | 2.41 | Why? |
| Fecal Microbiota Transplantation | 15 | 2021 | 372 | 2.28 | Why? |
| Rifamycins | 4 | 2018 | 20 | 2.18 | Why? |
| Carcinoma, Hepatocellular | 19 | 2019 | 1222 | 1.81 | Why? |
| Probiotics | 10 | 2019 | 694 | 1.70 | Why? |
| Intestines | 9 | 2018 | 817 | 1.65 | Why? |
| Liver Neoplasms | 20 | 2019 | 1666 | 1.65 | Why? |
| Gastrointestinal Agents | 6 | 2019 | 393 | 1.61 | Why? |
| Liver Cirrhosis | 14 | 2021 | 1810 | 1.39 | Why? |
| Inflammatory Bowel Diseases | 21 | 2021 | 3209 | 1.37 | Why? |
| Dysbiosis | 7 | 2019 | 685 | 1.20 | Why? |
| Proton Pump Inhibitors | 3 | 2018 | 377 | 1.12 | Why? |
| Diverticular Diseases | 3 | 2018 | 26 | 1.07 | Why? |
| Crohn Disease | 8 | 2019 | 959 | 1.03 | Why? |
| Clostridium Infections | 10 | 2020 | 595 | 0.98 | Why? |
| Heavy Ion Radiotherapy | 2 | 2019 | 26 | 0.96 | Why? |
| Gastrointestinal Diseases | 8 | 2020 | 2580 | 0.96 | Why? |
| Intestinal Mucosa | 11 | 2020 | 1046 | 0.94 | Why? |
| Hepatitis C, Chronic | 8 | 2019 | 973 | 0.88 | Why? |
| Anti-Bacterial Agents | 13 | 2019 | 10083 | 0.86 | Why? |
| Common Bile Duct | 1 | 2019 | 21 | 0.83 | Why? |
| Prebiotics | 2 | 2017 | 53 | 0.82 | Why? |
| Chordoma | 1 | 2019 | 10 | 0.81 | Why? |
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 2019 | 237 | 0.81 | Why? |
| Malabsorption Syndromes | 1 | 2019 | 19 | 0.78 | Why? |
| Pedicle Screws | 1 | 2018 | 16 | 0.78 | Why? |
| Metabolic Syndrome | 5 | 2018 | 810 | 0.78 | Why? |
| Bacterial Translocation | 4 | 2020 | 39 | 0.78 | Why? |
| Bacillus clausii | 1 | 2018 | 4 | 0.77 | Why? |
| Bone Cements | 1 | 2018 | 21 | 0.76 | Why? |
| Triticum | 1 | 2019 | 54 | 0.76 | Why? |
| Celiac Disease | 3 | 2019 | 471 | 0.76 | Why? |
| Polymethyl Methacrylate | 1 | 2018 | 51 | 0.74 | Why? |
| Bacteroidetes | 1 | 2018 | 36 | 0.74 | Why? |
| Colitis, Ulcerative | 7 | 2019 | 1037 | 0.74 | Why? |
| Liver Diseases | 9 | 2020 | 2698 | 0.72 | Why? |
| Proteobacteria | 1 | 2017 | 36 | 0.72 | Why? |
| Phenylurea Compounds | 1 | 2018 | 101 | 0.70 | Why? |
| Gastrointestinal Tract | 6 | 2020 | 1113 | 0.70 | Why? |
| Actinobacteria | 1 | 2018 | 87 | 0.69 | Why? |
| Stomach | 1 | 2018 | 141 | 0.69 | Why? |
| Bacterial Physiological Phenomena | 1 | 2017 | 31 | 0.69 | Why? |
| Hypertension, Portal | 1 | 2018 | 73 | 0.69 | Why? |
| Non-alcoholic Fatty Liver Disease | 8 | 2020 | 907 | 0.68 | Why? |
| Spine | 1 | 2020 | 292 | 0.68 | Why? |
| Diet, Gluten-Free | 1 | 2019 | 185 | 0.67 | Why? |
| Catheterization | 1 | 2019 | 264 | 0.67 | Why? |
| Esophageal and Gastric Varices | 1 | 2018 | 117 | 0.65 | Why? |
| Health | 1 | 2017 | 130 | 0.63 | Why? |
| Liver | 13 | 2020 | 4007 | 0.62 | Why? |
| Lymphatic Diseases | 1 | 2016 | 96 | 0.61 | Why? |
| Disease | 1 | 2017 | 126 | 0.61 | Why? |
| Sarcopenia | 2 | 2018 | 422 | 0.60 | Why? |
| Leukocyte L1 Antigen Complex | 2 | 2017 | 238 | 0.59 | Why? |
| Infliximab | 3 | 2019 | 502 | 0.59 | Why? |
| Permeability | 7 | 2020 | 238 | 0.57 | Why? |
| Bacteria | 5 | 2019 | 1897 | 0.57 | Why? |
| Homeostasis | 1 | 2018 | 582 | 0.53 | Why? |
| Chemical and Drug Induced Liver Injury | 5 | 2019 | 451 | 0.53 | Why? |
| Pancreatitis | 2 | 2019 | 688 | 0.52 | Why? |
| Tumor Necrosis Factor-alpha | 8 | 2020 | 2483 | 0.52 | Why? |
| Diet | 4 | 2021 | 2052 | 0.51 | Why? |
| Humans | 202 | 2021 | 930598 | 0.50 | Why? |
| Gastrointestinal Hemorrhage | 2 | 2020 | 669 | 0.50 | Why? |
| Italy | 34 | 2021 | 38444 | 0.48 | Why? |
| Calcium | 1 | 2018 | 708 | 0.48 | Why? |
| Pyridines | 1 | 2018 | 680 | 0.48 | Why? |
| Liver Function Tests | 6 | 2020 | 1325 | 0.47 | Why? |
| Stomach Neoplasms | 1 | 2018 | 477 | 0.47 | Why? |
| Medicine | 1 | 2019 | 485 | 0.46 | Why? |
| Donor Selection | 5 | 2021 | 804 | 0.45 | Why? |
| Intestinal Diseases | 3 | 2019 | 231 | 0.44 | Why? |
| Diarrhea | 5 | 2018 | 2743 | 0.43 | Why? |
| Chemoembolization, Therapeutic | 3 | 2018 | 144 | 0.43 | Why? |
| Pain | 1 | 2019 | 1084 | 0.42 | Why? |
| Metformin | 1 | 2018 | 640 | 0.42 | Why? |
| Nickel | 2 | 2021 | 55 | 0.41 | Why? |
| Telangiectasia, Hereditary Hemorrhagic | 2 | 2020 | 51 | 0.41 | Why? |
| Nutritional Status | 6 | 2021 | 1403 | 0.40 | Why? |
| Bacterial Infections | 3 | 2019 | 2229 | 0.40 | Why? |
| Endosonography | 4 | 2018 | 150 | 0.39 | Why? |
| Microbiota | 3 | 2020 | 1240 | 0.38 | Why? |
| Hepatitis C | 5 | 2018 | 1514 | 0.38 | Why? |
| Body Mass Index | 4 | 2019 | 4306 | 0.37 | Why? |
| Ablation Techniques | 2 | 2019 | 54 | 0.37 | Why? |
| Alzheimer Disease | 1 | 2019 | 1020 | 0.37 | Why? |
| Intestinal Absorption | 2 | 2018 | 64 | 0.36 | Why? |
| Polyethylene Glycols | 2 | 2017 | 574 | 0.36 | Why? |
| Pancreatic Ducts | 2 | 2018 | 29 | 0.36 | Why? |
| Multiple Organ Failure | 1 | 2019 | 1724 | 0.36 | Why? |
| Hepatic Encephalopathy | 2 | 2018 | 88 | 0.35 | Why? |
| Feces | 10 | 2021 | 4235 | 0.35 | Why? |
| Hepacivirus | 3 | 2018 | 1509 | 0.35 | Why? |
| Pancreas | 3 | 2019 | 398 | 0.34 | Why? |
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 2 | 2018 | 75 | 0.34 | Why? |
| Cell-Derived Microparticles | 2 | 2018 | 134 | 0.32 | Why? |
| Neoplasm Staging | 9 | 2019 | 1999 | 0.32 | Why? |
| Carbon | 2 | 2019 | 269 | 0.31 | Why? |
| Fabry Disease | 2 | 2018 | 106 | 0.31 | Why? |
| alpha-Fetoproteins | 4 | 2018 | 72 | 0.31 | Why? |
| Brain | 3 | 2019 | 5133 | 0.31 | Why? |
| Ribavirin | 2 | 2018 | 1182 | 0.30 | Why? |
| Middle Aged | 71 | 2021 | 270681 | 0.30 | Why? |
| Gastroenterologists | 2 | 2021 | 259 | 0.30 | Why? |
| Pancreatic Neoplasms | 3 | 2017 | 609 | 0.30 | Why? |
| Female | 85 | 2021 | 380317 | 0.30 | Why? |
| Male | 82 | 2021 | 367725 | 0.30 | Why? |
| Pancreatic Diseases | 2 | 2018 | 191 | 0.29 | Why? |
| Colitis | 2 | 2018 | 266 | 0.29 | Why? |
| Colon | 4 | 2019 | 669 | 0.29 | Why? |
| Patient Selection | 6 | 2020 | 4560 | 0.29 | Why? |
| Patient Care Team | 2 | 2019 | 3556 | 0.29 | Why? |
| Intestine, Small | 2 | 2018 | 336 | 0.28 | Why? |
| Asthma | 2 | 2021 | 4383 | 0.28 | Why? |
| Homocysteine | 1 | 2005 | 83 | 0.28 | Why? |
| Hydrogen | 1 | 2005 | 195 | 0.28 | Why? |
| Gastroenterology | 3 | 2020 | 1352 | 0.27 | Why? |
| Colonoscopy | 4 | 2018 | 738 | 0.27 | Why? |
| Aged | 57 | 2021 | 215776 | 0.27 | Why? |
| Adult | 56 | 2021 | 244371 | 0.27 | Why? |
| Drug Therapy, Combination | 9 | 2019 | 7268 | 0.27 | Why? |
| Helicobacter felis | 1 | 2003 | 1 | 0.26 | Why? |
| Treatment Outcome | 25 | 2020 | 51732 | 0.26 | Why? |
| Interferon-alpha | 1 | 2012 | 1442 | 0.26 | Why? |
| Glucose | 2 | 2018 | 573 | 0.25 | Why? |
| Osteoma, Osteoid | 1 | 2002 | 6 | 0.25 | Why? |
| Lactose Intolerance | 2 | 2016 | 9 | 0.25 | Why? |
| Physicians | 2 | 2021 | 4214 | 0.25 | Why? |
| Glutens | 1 | 2003 | 55 | 0.25 | Why? |
| Digestive System Diseases | 1 | 2008 | 378 | 0.25 | Why? |
| Lactulose | 2 | 2018 | 9 | 0.24 | Why? |
| Stem Cell Transplantation | 1 | 2008 | 531 | 0.24 | Why? |
| Breath Tests | 4 | 2018 | 338 | 0.24 | Why? |
| Catheter Ablation | 3 | 2018 | 438 | 0.24 | Why? |
| Metabolic Diseases | 2 | 2018 | 505 | 0.24 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.23 | Why? |
| Malnutrition | 4 | 2021 | 932 | 0.23 | Why? |
| Hepatitis, Alcoholic | 2 | 2019 | 61 | 0.23 | Why? |
| Cross-Over Studies | 4 | 2019 | 867 | 0.23 | Why? |
| Stem Cells | 1 | 2008 | 595 | 0.23 | Why? |
| Inflammation | 10 | 2020 | 13255 | 0.23 | Why? |
| Animals | 20 | 2020 | 78931 | 0.23 | Why? |
| Cystitis, Interstitial | 1 | 2021 | 36 | 0.23 | Why? |
| Iron | 2 | 2017 | 619 | 0.22 | Why? |
| Spinal Neoplasms | 1 | 2002 | 95 | 0.22 | Why? |
| Biomarkers | 7 | 2018 | 23361 | 0.22 | Why? |
| Aged, 80 and over | 29 | 2021 | 88759 | 0.22 | Why? |
| Liver Transplantation | 4 | 2018 | 2864 | 0.22 | Why? |
| Lipopolysaccharides | 3 | 2020 | 848 | 0.22 | Why? |
| Distance Counseling | 1 | 2021 | 76 | 0.21 | Why? |
| Lumbar Vertebrae | 1 | 2002 | 196 | 0.21 | Why? |
| Retrospective Studies | 25 | 2021 | 105322 | 0.21 | Why? |
| Osteopontin | 1 | 2021 | 96 | 0.21 | Why? |
| Contrast Media | 4 | 2019 | 1011 | 0.21 | Why? |
| fas Receptor | 1 | 2020 | 85 | 0.21 | Why? |
| Lipomatosis, Multiple Symmetrical | 1 | 2019 | 4 | 0.21 | Why? |
| Internal Medicine | 3 | 2021 | 557 | 0.21 | Why? |
| Antiviral Agents | 13 | 2020 | 41703 | 0.21 | Why? |
| Body Composition | 3 | 2018 | 414 | 0.20 | Why? |
| History, Medieval | 1 | 2020 | 131 | 0.20 | Why? |
| Spondylolisthesis | 1 | 2019 | 5 | 0.20 | Why? |
| Tuberculosis, Spinal | 1 | 2019 | 9 | 0.20 | Why? |
| Gastroenterostomy | 1 | 2019 | 5 | 0.20 | Why? |
| Diet, Fat-Restricted | 1 | 2019 | 15 | 0.20 | Why? |
| Enterocolitis, Pseudomembranous | 2 | 2018 | 93 | 0.20 | Why? |
| Prognosis | 19 | 2021 | 32490 | 0.20 | Why? |
| Bacteriocins | 1 | 2019 | 13 | 0.20 | Why? |
| Alcoholism | 2 | 2017 | 691 | 0.20 | Why? |
| Growth Substances | 1 | 2018 | 9 | 0.20 | Why? |
| Sacrum | 1 | 2019 | 41 | 0.20 | Why? |
| Endoscopy | 2 | 2018 | 1564 | 0.19 | Why? |
| Mannitol | 1 | 2018 | 34 | 0.19 | Why? |
| Sleep Aids, Pharmaceutical | 1 | 2019 | 52 | 0.19 | Why? |
| Catheters | 1 | 2019 | 93 | 0.19 | Why? |
| TRPM Cation Channels | 1 | 2018 | 25 | 0.19 | Why? |
| End Stage Liver Disease | 3 | 2018 | 418 | 0.19 | Why? |
| Single-Balloon Enteroscopy | 1 | 2018 | 5 | 0.19 | Why? |
| Fibrin Tissue Adhesive | 1 | 2018 | 11 | 0.19 | Why? |
| Symbiosis | 1 | 2018 | 38 | 0.19 | Why? |
| Risk Factors | 17 | 2021 | 71621 | 0.19 | Why? |
| History, 16th Century | 1 | 2019 | 104 | 0.19 | Why? |
| Eosinophilic Esophagitis | 1 | 2019 | 35 | 0.19 | Why? |
| Drug Screening Assays, Antitumor | 1 | 2018 | 138 | 0.19 | Why? |
| Paresthesia | 1 | 2019 | 134 | 0.19 | Why? |
| Pancreas, Exocrine | 1 | 2018 | 51 | 0.19 | Why? |
| Ankle Brachial Index | 1 | 2018 | 53 | 0.18 | Why? |
| Obesity | 6 | 2021 | 7388 | 0.18 | Why? |
| Immunity, Mucosal | 2 | 2019 | 426 | 0.18 | Why? |
| Magnesium Deficiency | 1 | 2018 | 28 | 0.18 | Why? |
| Disease Progression | 9 | 2020 | 13580 | 0.18 | Why? |
| Spinal Fusion | 1 | 2019 | 76 | 0.18 | Why? |
| Sulfasalazine | 1 | 2018 | 87 | 0.18 | Why? |
| Spectrometry, Mass, Secondary Ion | 1 | 2017 | 1 | 0.18 | Why? |
| Programmed Cell Death 1 Receptor | 2 | 2020 | 724 | 0.18 | Why? |
| History, 17th Century | 1 | 2019 | 172 | 0.18 | Why? |
| alpha-Galactosidase | 1 | 2018 | 32 | 0.18 | Why? |
| Abortion, Habitual | 1 | 2018 | 35 | 0.18 | Why? |
| Betacoronavirus | 13 | 2020 | 204454 | 0.18 | Why? |
| Drug Synergism | 2 | 2019 | 833 | 0.18 | Why? |
| Neoplasms, Glandular and Epithelial | 1 | 2018 | 39 | 0.18 | Why? |
| Hepatitis Antibodies | 1 | 2019 | 100 | 0.18 | Why? |
| Bifidobacterium | 1 | 2018 | 52 | 0.18 | Why? |
| Vipoma | 1 | 2017 | 1 | 0.18 | Why? |
| Adenocarcinoma, Papillary | 1 | 2017 | 9 | 0.18 | Why? |
| X-ray Repair Cross Complementing Protein 1 | 1 | 2017 | 6 | 0.18 | Why? |
| Intestinal Neoplasms | 1 | 2018 | 42 | 0.18 | Why? |
| Pneumonia, Viral | 13 | 2020 | 243684 | 0.18 | Why? |
| Endometrium | 1 | 2018 | 68 | 0.18 | Why? |
| Chenodeoxycholic Acid | 1 | 2017 | 9 | 0.18 | Why? |
| Principal Component Analysis | 2 | 2017 | 689 | 0.18 | Why? |
| Cholagogues and Choleretics | 1 | 2017 | 11 | 0.18 | Why? |
| Lymphopenia | 2 | 2020 | 2669 | 0.18 | Why? |
| Lactobacillus reuteri | 1 | 2017 | 16 | 0.18 | Why? |
| Drug Resistance, Bacterial | 2 | 2018 | 1414 | 0.17 | Why? |
| Coronavirus Infections | 13 | 2020 | 253789 | 0.17 | Why? |
| Biomechanical Phenomena | 1 | 2018 | 291 | 0.17 | Why? |
| Adenocarcinoma, Mucinous | 1 | 2017 | 27 | 0.17 | Why? |
| Reoperation | 2 | 2019 | 544 | 0.17 | Why? |
| Ursodeoxycholic Acid | 1 | 2017 | 25 | 0.17 | Why? |
| Clinical Protocols | 2 | 2020 | 2734 | 0.17 | Why? |
| Ultrasonography, Doppler, Color | 1 | 2018 | 107 | 0.17 | Why? |
| Dopamine Plasma Membrane Transport Proteins | 1 | 2017 | 37 | 0.17 | Why? |
| Methane | 1 | 2017 | 26 | 0.17 | Why? |
| Liver Diseases, Alcoholic | 1 | 2018 | 101 | 0.17 | Why? |
| Cachexia | 1 | 2018 | 75 | 0.17 | Why? |
| Needles | 1 | 2018 | 87 | 0.17 | Why? |
| Neoplasm Recurrence, Local | 4 | 2018 | 1063 | 0.17 | Why? |
| Muscular Atrophy | 1 | 2018 | 76 | 0.17 | Why? |
| Cholecystitis, Acute | 1 | 2020 | 234 | 0.17 | Why? |
| Interleukin-33 | 1 | 2018 | 120 | 0.17 | Why? |
| Cholestasis, Intrahepatic | 1 | 2017 | 28 | 0.17 | Why? |
| Pyrrolidinones | 1 | 2017 | 66 | 0.17 | Why? |
| Radiology, Interventional | 2 | 2019 | 398 | 0.17 | Why? |
| Molecular Mimicry | 1 | 2019 | 190 | 0.17 | Why? |
| Amyloid beta-Peptides | 1 | 2019 | 185 | 0.17 | Why? |
| Genetic Techniques | 1 | 2017 | 79 | 0.17 | Why? |
| Hypocalcemia | 1 | 2018 | 120 | 0.16 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2018 | 9659 | 0.16 | Why? |
| Cohort Studies | 12 | 2021 | 36005 | 0.16 | Why? |
| Endotoxemia | 1 | 2018 | 143 | 0.16 | Why? |
| Hand Dermatoses | 1 | 2021 | 284 | 0.16 | Why? |
| Anti-Inflammatory Agents | 3 | 2017 | 6153 | 0.16 | Why? |
| Food Hypersensitivity | 2 | 2021 | 397 | 0.16 | Why? |
| Familial Mediterranean Fever | 1 | 2017 | 88 | 0.16 | Why? |
| Dermatitis, Occupational | 1 | 2021 | 310 | 0.16 | Why? |
| Skin Diseases, Bacterial | 1 | 2017 | 105 | 0.16 | Why? |
| Antibodies, Monoclonal | 3 | 2017 | 8041 | 0.16 | Why? |
| Ustekinumab | 1 | 2018 | 216 | 0.16 | Why? |
| Age of Onset | 1 | 2018 | 557 | 0.16 | Why? |
| Hospitals, High-Volume | 1 | 2020 | 688 | 0.16 | Why? |
| Fever of Unknown Origin | 1 | 2017 | 93 | 0.16 | Why? |
| Radial Artery | 1 | 2017 | 132 | 0.16 | Why? |
| Common Variable Immunodeficiency | 1 | 2019 | 195 | 0.16 | Why? |
| Tumor Burden | 1 | 2018 | 369 | 0.16 | Why? |
| Constipation | 1 | 2017 | 99 | 0.16 | Why? |
| Digestive System Neoplasms | 1 | 2018 | 146 | 0.16 | Why? |
| Neoplasms | 4 | 2020 | 17251 | 0.15 | Why? |
| Cholangitis | 1 | 2017 | 81 | 0.15 | Why? |
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 112 | 0.15 | Why? |
| Survival Rate | 6 | 2021 | 9206 | 0.15 | Why? |
| Bacteriophages | 1 | 2019 | 268 | 0.15 | Why? |
| Severity of Illness Index | 14 | 2021 | 48226 | 0.15 | Why? |
| Magnesium | 1 | 2018 | 290 | 0.15 | Why? |
| Spondylarthritis | 1 | 2018 | 174 | 0.15 | Why? |
| Migraine Disorders | 1 | 2003 | 530 | 0.15 | Why? |
| Transcranial Magnetic Stimulation | 1 | 2017 | 160 | 0.15 | Why? |
| Prefrontal Cortex | 1 | 2017 | 151 | 0.15 | Why? |
| Macular Degeneration | 1 | 2018 | 194 | 0.15 | Why? |
| Therapies, Investigational | 1 | 2018 | 235 | 0.15 | Why? |
| Off-Label Use | 1 | 2020 | 553 | 0.15 | Why? |
| Immunologic Factors | 3 | 2018 | 4206 | 0.15 | Why? |
| Diet, Ketogenic | 1 | 2017 | 109 | 0.15 | Why? |
| Pilot Projects | 5 | 2018 | 5182 | 0.15 | Why? |
| Hospital Mortality | 9 | 2021 | 22087 | 0.15 | Why? |
| Ultrasonography | 4 | 2020 | 4409 | 0.15 | Why? |
| Antigens, Neoplasm | 1 | 2017 | 230 | 0.15 | Why? |
| Urea | 1 | 2017 | 228 | 0.15 | Why? |
| Peritonitis | 1 | 2017 | 217 | 0.15 | Why? |
| Femoral Artery | 1 | 2017 | 213 | 0.15 | Why? |
| Diagnosis, Differential | 6 | 2020 | 7220 | 0.15 | Why? |
| Dextran Sulfate | 3 | 2019 | 54 | 0.15 | Why? |
| Risk Assessment | 7 | 2021 | 25439 | 0.15 | Why? |
| Drainage | 1 | 2019 | 414 | 0.15 | Why? |
| Neoplasm Invasiveness | 4 | 2018 | 582 | 0.14 | Why? |
| Vancomycin | 1 | 2018 | 328 | 0.14 | Why? |
| Regeneration | 1 | 2018 | 429 | 0.14 | Why? |
| Energy Intake | 1 | 2017 | 323 | 0.14 | Why? |
| Hepatitis E virus | 1 | 2019 | 306 | 0.14 | Why? |
| Troponin T | 1 | 2020 | 771 | 0.14 | Why? |
| Neoadjuvant Therapy | 1 | 2018 | 554 | 0.14 | Why? |
| Length of Stay | 5 | 2019 | 11042 | 0.14 | Why? |
| Anemia, Iron-Deficiency | 1 | 2017 | 210 | 0.14 | Why? |
| Hospitalization | 9 | 2021 | 54280 | 0.14 | Why? |
| Metals | 1 | 2016 | 182 | 0.14 | Why? |
| Erythema | 1 | 2019 | 400 | 0.14 | Why? |
| Fibrosis | 1 | 2018 | 800 | 0.14 | Why? |
| Models, Economic | 1 | 2017 | 316 | 0.14 | Why? |
| Micronutrients | 1 | 2018 | 310 | 0.14 | Why? |
| Genome | 1 | 2017 | 341 | 0.14 | Why? |
| Nutrition Therapy | 1 | 2019 | 285 | 0.14 | Why? |
| Analgesics | 1 | 2019 | 451 | 0.14 | Why? |
| Counseling | 1 | 2020 | 747 | 0.14 | Why? |
| Methotrexate | 1 | 2018 | 471 | 0.14 | Why? |
| Biopsy | 3 | 2017 | 2811 | 0.14 | Why? |
| Diet, Mediterranean | 1 | 2019 | 351 | 0.14 | Why? |
| Abdominal Pain | 2 | 2018 | 858 | 0.14 | Why? |
| Hepatitis E | 1 | 2019 | 319 | 0.14 | Why? |
| Biliary Tract Diseases | 2 | 2005 | 60 | 0.13 | Why? |
| Embolization, Therapeutic | 1 | 2017 | 269 | 0.13 | Why? |
| Acetaminophen | 1 | 2017 | 326 | 0.13 | Why? |
| Delivery of Health Care | 2 | 2020 | 15909 | 0.13 | Why? |
| Observational Studies as Topic | 2 | 2018 | 1887 | 0.13 | Why? |
| ROC Curve | 3 | 2021 | 6024 | 0.13 | Why? |
| Recurrence | 6 | 2020 | 3675 | 0.13 | Why? |
| Tertiary Healthcare | 1 | 2018 | 616 | 0.13 | Why? |
| Gastrointestinal Neoplasms | 1 | 2019 | 392 | 0.13 | Why? |
| Th17 Cells | 1 | 2019 | 657 | 0.13 | Why? |
| Dermatitis, Allergic Contact | 1 | 2016 | 185 | 0.13 | Why? |
| Cardiovascular Diseases | 4 | 2018 | 11497 | 0.13 | Why? |
| Methylprednisolone | 1 | 2004 | 2107 | 0.13 | Why? |
| Amino Acids | 1 | 2017 | 552 | 0.13 | Why? |
| Surgical Procedures, Operative | 2 | 2020 | 2662 | 0.13 | Why? |
| Endoscopy, Digestive System | 1 | 2017 | 352 | 0.13 | Why? |
| Liver Failure, Acute | 1 | 2017 | 279 | 0.13 | Why? |
| Vascular Calcification | 1 | 2018 | 396 | 0.13 | Why? |
| Colonic Neoplasms | 1 | 2017 | 295 | 0.13 | Why? |
| Nutritional Support | 1 | 2018 | 447 | 0.13 | Why? |
| Lymphocyte Subsets | 1 | 2020 | 987 | 0.13 | Why? |
| Case-Control Studies | 7 | 2018 | 17671 | 0.13 | Why? |
| Balloon Occlusion | 1 | 2013 | 39 | 0.13 | Why? |
| Biological Specimen Banks | 1 | 2021 | 1142 | 0.13 | Why? |
| Oral Health | 1 | 2017 | 401 | 0.12 | Why? |
| Species Specificity | 1 | 2017 | 1356 | 0.12 | Why? |
| Quality of Life | 5 | 2021 | 9820 | 0.12 | Why? |
| Fatty Liver | 1 | 2017 | 299 | 0.12 | Why? |
| Takotsubo Cardiomyopathy | 1 | 2019 | 453 | 0.12 | Why? |
| Specimen Handling | 3 | 2020 | 6190 | 0.12 | Why? |
| Organ Dysfunction Scores | 1 | 2019 | 1475 | 0.12 | Why? |
| Quinolines | 1 | 2017 | 403 | 0.12 | Why? |
| Sustained Virologic Response | 3 | 2019 | 378 | 0.12 | Why? |
| Overweight | 1 | 2019 | 916 | 0.12 | Why? |
| Neutrophils | 2 | 2021 | 5476 | 0.12 | Why? |
| Steroids | 1 | 2018 | 904 | 0.12 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.12 | Why? |
| Ovarian Neoplasms | 1 | 2018 | 465 | 0.12 | Why? |
| Idiopathic Pulmonary Fibrosis | 1 | 2019 | 595 | 0.12 | Why? |
| Double-Blind Method | 4 | 2019 | 5988 | 0.12 | Why? |
| Alcohol Drinking | 3 | 2018 | 1663 | 0.12 | Why? |
| Peripheral Arterial Disease | 1 | 2018 | 471 | 0.12 | Why? |
| Sepsis | 2 | 2019 | 3517 | 0.12 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.12 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2019 | 830 | 0.11 | Why? |
| Disease Eradication | 1 | 2018 | 581 | 0.11 | Why? |
| Pandemics | 22 | 2021 | 389249 | 0.11 | Why? |
| Immune System | 2 | 2019 | 1479 | 0.11 | Why? |
| Hepatitis C Antibodies | 1 | 2012 | 120 | 0.11 | Why? |
| Vascular Diseases | 1 | 2020 | 846 | 0.11 | Why? |
| Muscle, Skeletal | 1 | 2018 | 915 | 0.11 | Why? |
| Acute Disease | 3 | 2019 | 6029 | 0.11 | Why? |
| Prospective Studies | 14 | 2021 | 43301 | 0.11 | Why? |
| Polymorphism, Genetic | 1 | 2018 | 1074 | 0.11 | Why? |
| Antibodies | 1 | 2017 | 846 | 0.11 | Why? |
| Viremia | 1 | 2018 | 1020 | 0.11 | Why? |
| Hypersensitivity | 1 | 2021 | 1137 | 0.11 | Why? |
| Blood Transfusion | 1 | 2020 | 1399 | 0.11 | Why? |
| Digestive System Surgical Procedures | 1 | 2018 | 677 | 0.11 | Why? |
| Colchicine | 1 | 2017 | 730 | 0.11 | Why? |
| Health Care Costs | 1 | 2019 | 1007 | 0.10 | Why? |
| Immunosuppressive Agents | 2 | 2020 | 6331 | 0.10 | Why? |
| Lipids | 1 | 2017 | 1079 | 0.10 | Why? |
| Coronary Vessels | 1 | 2018 | 914 | 0.10 | Why? |
| Patient Preference | 1 | 2017 | 750 | 0.10 | Why? |
| Postoperative Complications | 2 | 2019 | 5861 | 0.10 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2018 | 1454 | 0.10 | Why? |
| Anemia | 1 | 2017 | 789 | 0.10 | Why? |
| Pain Management | 1 | 2019 | 854 | 0.10 | Why? |
| Virulence | 1 | 2017 | 2172 | 0.10 | Why? |
| Evidence-Based Medicine | 3 | 2018 | 3228 | 0.10 | Why? |
| Cost of Illness | 2 | 2018 | 1903 | 0.10 | Why? |
| Atherosclerosis | 1 | 2018 | 768 | 0.10 | Why? |
| Alanine Transaminase | 3 | 2020 | 1329 | 0.10 | Why? |
| Cognition | 1 | 2019 | 1394 | 0.10 | Why? |
| Genital Diseases, Female | 1 | 2010 | 110 | 0.10 | Why? |
| RNA | 1 | 2017 | 1278 | 0.10 | Why? |
| Frailty | 1 | 2021 | 1432 | 0.10 | Why? |
| Antioxidants | 1 | 2019 | 1593 | 0.10 | Why? |
| Neurodegenerative Diseases | 1 | 2015 | 469 | 0.10 | Why? |
| Ambulatory Care Facilities | 1 | 2021 | 2063 | 0.10 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2019 | 1458 | 0.09 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.09 | Why? |
| gamma-Glutamyltransferase | 2 | 2020 | 101 | 0.09 | Why? |
| Aspartate Aminotransferases | 3 | 2020 | 1394 | 0.09 | Why? |
| Nervous System Diseases | 2 | 2018 | 4092 | 0.09 | Why? |
| Monocytes | 1 | 2021 | 2978 | 0.09 | Why? |
| Hematologic Diseases | 1 | 2015 | 614 | 0.09 | Why? |
| Endometriosis | 1 | 2010 | 130 | 0.09 | Why? |
| Critical Pathways | 1 | 2019 | 1587 | 0.09 | Why? |
| 2-Naphthylamine | 2 | 2018 | 54 | 0.09 | Why? |
| Life Style | 2 | 2018 | 2708 | 0.09 | Why? |
| Emotions | 1 | 2021 | 2418 | 0.09 | Why? |
| Tomography, Emission-Computed, Single-Photon | 2 | 2017 | 279 | 0.09 | Why? |
| Clinical Decision-Making | 2 | 2020 | 3755 | 0.09 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.09 | Why? |
| Loneliness | 1 | 2020 | 1766 | 0.09 | Why? |
| Depressive Disorder | 1 | 2018 | 1236 | 0.09 | Why? |
| Tomography, X-Ray Computed | 6 | 2021 | 25144 | 0.09 | Why? |
| Administration, Oral | 3 | 2021 | 2340 | 0.09 | Why? |
| Macrocyclic Compounds | 2 | 2018 | 78 | 0.09 | Why? |
| Maltose | 2 | 2017 | 50 | 0.09 | Why? |
| Arthritis, Rheumatoid | 1 | 2021 | 2043 | 0.09 | Why? |
| Uracil | 2 | 2018 | 101 | 0.08 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2020 | 9335 | 0.08 | Why? |
| Orthopedic Procedures | 1 | 2018 | 1231 | 0.08 | Why? |
| Lactams, Macrocyclic | 2 | 2018 | 130 | 0.08 | Why? |
| Patient Care Management | 1 | 2018 | 1514 | 0.08 | Why? |
| Blood Platelets | 1 | 2018 | 1704 | 0.08 | Why? |
| Anilides | 2 | 2018 | 105 | 0.08 | Why? |
| Perioperative Care | 1 | 2018 | 1329 | 0.08 | Why? |
| Prevalence | 8 | 2021 | 25773 | 0.08 | Why? |
| Cross-Sectional Studies | 9 | 2021 | 53120 | 0.08 | Why? |
| RNA, Viral | 3 | 2020 | 32276 | 0.08 | Why? |
| Ethiodized Oil | 2 | 2018 | 9 | 0.08 | Why? |
| Anti-Infective Agents | 1 | 2018 | 1766 | 0.08 | Why? |
| Diabetes Mellitus | 3 | 2018 | 8207 | 0.08 | Why? |
| Ferric Compounds | 2 | 2017 | 136 | 0.08 | Why? |
| Leukocyte Adherence Inhibition Test | 1 | 2005 | 4 | 0.08 | Why? |
| Kidney Diseases | 1 | 2017 | 1434 | 0.08 | Why? |
| Cytokines | 5 | 2020 | 15010 | 0.08 | Why? |
| Whole Genome Sequencing | 1 | 2017 | 3239 | 0.08 | Why? |
| Zoonoses | 1 | 2020 | 3034 | 0.08 | Why? |
| Databases, Factual | 5 | 2018 | 6248 | 0.08 | Why? |
| beta-Galactosidase | 1 | 2005 | 40 | 0.08 | Why? |
| Algorithms | 3 | 2020 | 7346 | 0.08 | Why? |
| Valine | 2 | 2018 | 359 | 0.08 | Why? |
| Aging | 2 | 2020 | 3581 | 0.07 | Why? |
| Interleukin-6 | 2 | 2020 | 7522 | 0.07 | Why? |
| Melanoma | 1 | 2017 | 1229 | 0.07 | Why? |
| Postoperative Period | 2 | 2018 | 651 | 0.07 | Why? |
| Adaptive Immunity | 1 | 2017 | 2585 | 0.07 | Why? |
| Hospitals, University | 1 | 2018 | 4173 | 0.07 | Why? |
| Proline | 2 | 2018 | 345 | 0.07 | Why? |
| Antineoplastic Agents | 2 | 2018 | 3550 | 0.07 | Why? |
| MicroRNAs | 1 | 2018 | 1787 | 0.07 | Why? |
| Emergency Service, Hospital | 5 | 2021 | 14232 | 0.07 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.07 | Why? |
| Biological Products | 1 | 2020 | 2331 | 0.07 | Why? |
| Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 121 | 0.07 | Why? |
| Cyclopropanes | 2 | 2018 | 332 | 0.07 | Why? |
| Magnetic Resonance Imaging | 2 | 2019 | 6551 | 0.07 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.07 | Why? |
| Randomized Controlled Trials as Topic | 3 | 2018 | 10649 | 0.07 | Why? |
| Venous Thrombosis | 1 | 2020 | 2739 | 0.07 | Why? |
| Mobile Applications | 1 | 2021 | 3032 | 0.07 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.07 | Why? |
| Caco-2 Cells | 2 | 2019 | 1236 | 0.07 | Why? |
| Substance-Related Disorders | 1 | 2019 | 2038 | 0.07 | Why? |
| Influenza Vaccines | 1 | 2021 | 2941 | 0.07 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.07 | Why? |
| Kaplan-Meier Estimate | 3 | 2019 | 4260 | 0.07 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
| Lung | 4 | 2021 | 31049 | 0.07 | Why? |
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 189 | 0.07 | Why? |
| Young Adult | 9 | 2021 | 93724 | 0.07 | Why? |
| Interferons | 1 | 2016 | 2885 | 0.07 | Why? |
| Carbamates | 2 | 2018 | 485 | 0.07 | Why? |
| Lymphocytes | 1 | 2017 | 3056 | 0.07 | Why? |
| Precision Medicine | 3 | 2018 | 1477 | 0.07 | Why? |
| Disease Models, Animal | 2 | 2019 | 10998 | 0.07 | Why? |
| Folic Acid | 1 | 2005 | 172 | 0.06 | Why? |
| Vitamin D | 1 | 2019 | 2904 | 0.06 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
| Time Factors | 5 | 2018 | 31397 | 0.06 | Why? |
| Pneumonia | 2 | 2020 | 5652 | 0.06 | Why? |
| Fever | 1 | 2020 | 7795 | 0.06 | Why? |
| Disease Management | 2 | 2018 | 6841 | 0.06 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.06 | Why? |
| Administration, Intravenous | 2 | 2017 | 1115 | 0.06 | Why? |
| Surveys and Questionnaires | 5 | 2021 | 43792 | 0.06 | Why? |
| Longitudinal Studies | 4 | 2021 | 9893 | 0.06 | Why? |
| Renal Dialysis | 2 | 2017 | 4358 | 0.06 | Why? |
| Chemokine CCL2 | 1 | 2005 | 389 | 0.06 | Why? |
| Combined Modality Therapy | 3 | 2018 | 3395 | 0.06 | Why? |
| Medical Oncology | 1 | 2019 | 3826 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Caregivers | 1 | 2017 | 3112 | 0.06 | Why? |
| CD48 Antigen | 1 | 2021 | 27 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.06 | Why? |
| Mass Screening | 2 | 2020 | 8005 | 0.06 | Why? |
| Reference Values | 1 | 2005 | 795 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2020 | 4273 | 0.06 | Why? |
| S100A12 Protein | 1 | 2021 | 43 | 0.06 | Why? |
| Child | 3 | 2021 | 70012 | 0.06 | Why? |
| Arthritis | 1 | 2005 | 288 | 0.06 | Why? |
| Synovial Membrane | 1 | 2021 | 72 | 0.06 | Why? |
| Fatty Acid-Binding Proteins | 1 | 2021 | 93 | 0.06 | Why? |
| Hernia | 1 | 2020 | 23 | 0.06 | Why? |
| Recombinant Proteins | 1 | 2012 | 3786 | 0.06 | Why? |
| Hemoglobins | 2 | 2017 | 958 | 0.05 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.05 | Why? |
| Program Evaluation | 2 | 2021 | 1929 | 0.05 | Why? |
| Host-Pathogen Interactions | 2 | 2018 | 11041 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Microcirculation | 1 | 2005 | 447 | 0.05 | Why? |
| Europe | 4 | 2019 | 12702 | 0.05 | Why? |
| Kidney Failure, Chronic | 1 | 2017 | 3222 | 0.05 | Why? |
| Survival Analysis | 3 | 2018 | 7592 | 0.05 | Why? |
| Sex Factors | 4 | 2018 | 11014 | 0.05 | Why? |
| Diverticulitis | 1 | 2020 | 65 | 0.05 | Why? |
| Pathogen-Associated Molecular Pattern Molecules | 1 | 2020 | 108 | 0.05 | Why? |
| Osteoporosis | 1 | 2005 | 410 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2018 | 3633 | 0.05 | Why? |
| Chromium Radioisotopes | 1 | 2019 | 3 | 0.05 | Why? |
| Analysis of Variance | 2 | 2018 | 950 | 0.05 | Why? |
| Gloves, Protective | 1 | 2021 | 249 | 0.05 | Why? |
| Incidence | 5 | 2020 | 25622 | 0.05 | Why? |
| Receptor Protein-Tyrosine Kinases | 1 | 2021 | 243 | 0.05 | Why? |
| Alkaline Phosphatase | 1 | 2020 | 257 | 0.05 | Why? |
| Cerebrovascular Circulation | 1 | 2003 | 340 | 0.05 | Why? |
| Bone Plates | 1 | 2019 | 26 | 0.05 | Why? |
| Herniorrhaphy | 1 | 2020 | 99 | 0.05 | Why? |
| Rectal Diseases | 1 | 2020 | 111 | 0.05 | Why? |
| San Marino | 1 | 2018 | 3 | 0.05 | Why? |
| Fatty Liver, Alcoholic | 1 | 2018 | 13 | 0.05 | Why? |
| Pancreaticojejunostomy | 1 | 2018 | 3 | 0.05 | Why? |
| Infusions, Intra-Arterial | 1 | 2018 | 36 | 0.05 | Why? |
| Infection Control | 4 | 2021 | 23131 | 0.05 | Why? |
| Tinidazole | 1 | 1998 | 9 | 0.05 | Why? |
| Adolescent | 5 | 2020 | 86841 | 0.05 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.05 | Why? |
| Anti-Ulcer Agents | 1 | 1998 | 24 | 0.05 | Why? |
| Alarmins | 1 | 2020 | 180 | 0.05 | Why? |
| Vitamin K | 1 | 2021 | 263 | 0.05 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.05 | Why? |
| Fructose | 1 | 2018 | 52 | 0.05 | Why? |
| Ranitidine | 1 | 1998 | 27 | 0.05 | Why? |
| Follow-Up Studies | 4 | 2018 | 17020 | 0.05 | Why? |
| Dental Plaque Index | 1 | 2017 | 7 | 0.05 | Why? |
| Edetic Acid | 1 | 2019 | 85 | 0.05 | Why? |
| Sulfonamides | 2 | 2018 | 1294 | 0.05 | Why? |
| Sensitivity and Specificity | 3 | 2018 | 22971 | 0.05 | Why? |
| Periodontal Index | 1 | 2017 | 16 | 0.05 | Why? |
| Lipopolysaccharide Receptors | 1 | 2021 | 357 | 0.05 | Why? |
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2018 | 92 | 0.05 | Why? |
| Benzophenones | 1 | 2017 | 18 | 0.05 | Why? |
| Phylogeny | 1 | 2017 | 13341 | 0.05 | Why? |
| Bismuth | 1 | 1998 | 56 | 0.04 | Why? |
| Ribotyping | 1 | 2017 | 54 | 0.04 | Why? |
| Transaminases | 1 | 2018 | 152 | 0.04 | Why? |
| Yttrium Radioisotopes | 1 | 2017 | 12 | 0.04 | Why? |
| Waist Circumference | 1 | 2019 | 199 | 0.04 | Why? |
| Intestinal Perforation | 1 | 2020 | 178 | 0.04 | Why? |
| Spectrometry, Mass, Electrospray Ionization | 1 | 2018 | 159 | 0.04 | Why? |
| Lectins | 1 | 2021 | 311 | 0.04 | Why? |
| Economics, Pharmaceutical | 1 | 2018 | 61 | 0.04 | Why? |
| United States | 3 | 2020 | 46150 | 0.04 | Why? |
| Injections, Intravenous | 1 | 2019 | 381 | 0.04 | Why? |
| Intestinal Obstruction | 1 | 2020 | 197 | 0.04 | Why? |
| Pancreaticoduodenectomy | 1 | 2018 | 60 | 0.04 | Why? |
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 13 | 0.04 | Why? |
| Smad4 Protein | 1 | 2017 | 15 | 0.04 | Why? |
| Tropanes | 1 | 2017 | 18 | 0.04 | Why? |
| Amoxicillin | 1 | 1998 | 98 | 0.04 | Why? |
| Mice, Inbred C57BL | 2 | 2019 | 5542 | 0.04 | Why? |
| Diet, High-Fat | 1 | 2018 | 161 | 0.04 | Why? |
| CTLA-4 Antigen | 1 | 2019 | 282 | 0.04 | Why? |
| Anthropometry | 1 | 2018 | 233 | 0.04 | Why? |
| Cost-Benefit Analysis | 2 | 2018 | 2259 | 0.04 | Why? |
| Urologic Diseases | 1 | 2005 | 860 | 0.04 | Why? |
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 45 | 0.04 | Why? |
| Skin Diseases | 2 | 2005 | 2509 | 0.04 | Why? |
| Neoplasm, Residual | 1 | 2018 | 147 | 0.04 | Why? |
| Self Expandable Metallic Stents | 1 | 2017 | 52 | 0.04 | Why? |
| Punctures | 1 | 2017 | 89 | 0.04 | Why? |
| Clarithromycin | 1 | 1998 | 112 | 0.04 | Why? |
| Neovascularization, Physiologic | 1 | 2018 | 160 | 0.04 | Why? |
| Anxiety | 2 | 2021 | 17311 | 0.04 | Why? |
| Bilirubin | 1 | 2020 | 503 | 0.04 | Why? |
| B7-H1 Antigen | 1 | 2021 | 541 | 0.04 | Why? |
| Fluoroscopy | 1 | 2017 | 140 | 0.04 | Why? |
| Tumor Microenvironment | 1 | 2019 | 264 | 0.04 | Why? |
| Cytoreduction Surgical Procedures | 1 | 2018 | 144 | 0.04 | Why? |
| Health Policy | 1 | 2017 | 6242 | 0.04 | Why? |
| Caloric Restriction | 1 | 2017 | 56 | 0.04 | Why? |
| Hepatocytes | 1 | 2020 | 549 | 0.04 | Why? |
| Receptors, Immunologic | 1 | 2021 | 555 | 0.04 | Why? |
| Preoperative Period | 1 | 2018 | 271 | 0.04 | Why? |
| DNA Repair | 1 | 2017 | 114 | 0.04 | Why? |
| Radiometry | 1 | 2017 | 136 | 0.04 | Why? |
| Radiotherapy Planning, Computer-Assisted | 1 | 2017 | 172 | 0.04 | Why? |
| Pulse Wave Analysis | 1 | 2018 | 221 | 0.04 | Why? |
| Neck | 1 | 2019 | 307 | 0.04 | Why? |
| Carotid Intima-Media Thickness | 1 | 2018 | 179 | 0.04 | Why? |
| Colistin | 1 | 2019 | 217 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.04 | Why? |
| Serum | 1 | 2018 | 294 | 0.04 | Why? |
| Device Removal | 1 | 2019 | 221 | 0.04 | Why? |
| Multivariate Analysis | 2 | 2018 | 5440 | 0.04 | Why? |
| Acetylcysteine | 1 | 2019 | 255 | 0.04 | Why? |
| Electric Impedance | 1 | 2019 | 283 | 0.04 | Why? |
| Cross Infection | 1 | 2019 | 8675 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2017 | 6817 | 0.04 | Why? |
| Lipoproteins, LDL | 1 | 2017 | 115 | 0.04 | Why? |
| Markov Chains | 1 | 2018 | 502 | 0.04 | Why? |
| Flow Cytometry | 1 | 2005 | 2393 | 0.04 | Why? |
| Ketones | 1 | 2017 | 150 | 0.04 | Why? |
| Integrins | 1 | 2017 | 158 | 0.04 | Why? |
| Technology Assessment, Biomedical | 1 | 2017 | 106 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Probability | 1 | 2020 | 923 | 0.04 | Why? |
| Cholestasis | 1 | 2017 | 114 | 0.04 | Why? |
| Inservice Training | 1 | 2020 | 477 | 0.04 | Why? |
| Radiotherapy Dosage | 1 | 2017 | 428 | 0.04 | Why? |
| Oral Hygiene | 1 | 2017 | 137 | 0.04 | Why? |
| Video Recording | 1 | 2002 | 786 | 0.04 | Why? |
| Acidosis | 1 | 2017 | 125 | 0.04 | Why? |
| Microspheres | 1 | 2017 | 261 | 0.04 | Why? |
| Blood Vessels | 1 | 2018 | 228 | 0.04 | Why? |
| Analgesics, Non-Narcotic | 1 | 2017 | 164 | 0.04 | Why? |
| Bacteriological Techniques | 1 | 2018 | 239 | 0.04 | Why? |
| Risk Adjustment | 1 | 2020 | 730 | 0.04 | Why? |
| Preliminary Data | 1 | 2017 | 457 | 0.04 | Why? |
| Radiography, Interventional | 1 | 2017 | 158 | 0.04 | Why? |
| Triglycerides | 1 | 2018 | 478 | 0.04 | Why? |
| Infant | 1 | 2018 | 30274 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Drugs, Investigational | 1 | 2018 | 198 | 0.04 | Why? |
| Absenteeism | 1 | 2017 | 287 | 0.04 | Why? |
| RNA, Ribosomal, 16S | 1 | 2018 | 793 | 0.04 | Why? |
| Hepatectomy | 1 | 2018 | 276 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2018 | 1008 | 0.04 | Why? |
| Lower Extremity | 1 | 2020 | 593 | 0.04 | Why? |
| Drug Resistance | 1 | 2017 | 395 | 0.04 | Why? |
| Necrosis | 1 | 2017 | 532 | 0.04 | Why? |
| Living Donors | 1 | 2020 | 652 | 0.03 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2018 | 669 | 0.03 | Why? |
| Proportional Hazards Models | 2 | 2018 | 6543 | 0.03 | Why? |
| Nausea | 1 | 2018 | 457 | 0.03 | Why? |
| Vascular Stiffness | 1 | 2018 | 264 | 0.03 | Why? |
| Eye Diseases | 1 | 2005 | 1150 | 0.03 | Why? |
| Cell Adhesion Molecules | 1 | 2017 | 472 | 0.03 | Why? |
| Platelet Activation | 1 | 2018 | 660 | 0.03 | Why? |
| Drug Costs | 1 | 2018 | 313 | 0.03 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2018 | 604 | 0.03 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.03 | Why? |
| Pain Measurement | 1 | 2017 | 533 | 0.03 | Why? |
| Gelatin Sponge, Absorbable | 1 | 2013 | 3 | 0.03 | Why? |
| Retina | 1 | 2018 | 424 | 0.03 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.03 | Why? |
| Mental Health | 1 | 2020 | 15770 | 0.03 | Why? |
| Nutrition Assessment | 1 | 2018 | 527 | 0.03 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.03 | Why? |
| Endothelium, Vascular | 1 | 2005 | 1751 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2018 | 1654 | 0.03 | Why? |
| Desensitization, Immunologic | 1 | 2019 | 574 | 0.03 | Why? |
| Rare Diseases | 1 | 2017 | 373 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Enoxaparin | 1 | 2020 | 1064 | 0.03 | Why? |
| Informed Consent | 1 | 2020 | 890 | 0.03 | Why? |
| Carboplatin | 1 | 2013 | 76 | 0.03 | Why? |
| Mesalamine | 1 | 2013 | 89 | 0.03 | Why? |
| Polymers | 1 | 2017 | 507 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 581 | 0.03 | Why? |
| Vomiting | 1 | 2018 | 722 | 0.03 | Why? |
| Body Weight | 1 | 2019 | 1074 | 0.03 | Why? |
| Thromboembolism | 1 | 2005 | 2101 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.03 | Why? |
| Age Factors | 3 | 2018 | 21039 | 0.03 | Why? |
| Radiation Dosage | 1 | 2017 | 585 | 0.03 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 1316 | 0.03 | Why? |
| Ritonavir | 2 | 2018 | 4212 | 0.03 | Why? |
| Geriatric Assessment | 1 | 2021 | 1372 | 0.03 | Why? |
| Chemokines | 1 | 2018 | 1095 | 0.03 | Why? |
| Activities of Daily Living | 1 | 2021 | 1530 | 0.03 | Why? |
| Fluid Therapy | 1 | 2017 | 628 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 2309 | 0.03 | Why? |
| Membrane Glycoproteins | 1 | 2021 | 2273 | 0.03 | Why? |
| Area Under Curve | 1 | 2019 | 2564 | 0.03 | Why? |
| Frail Elderly | 1 | 2021 | 1427 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Inflammasomes | 1 | 2018 | 710 | 0.03 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.03 | Why? |
| Patient Acuity | 1 | 2018 | 1755 | 0.03 | Why? |
| Surgery Department, Hospital | 1 | 2020 | 954 | 0.03 | Why? |
| Signal Transduction | 2 | 2018 | 7207 | 0.03 | Why? |
| Rats | 1 | 2018 | 2764 | 0.03 | Why? |
| Workflow | 1 | 2020 | 2373 | 0.03 | Why? |
| Appendicitis | 1 | 2020 | 946 | 0.03 | Why? |
| Treatment Failure | 1 | 2017 | 2106 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2019 | 1609 | 0.03 | Why? |
| Pelvic Pain | 1 | 2010 | 47 | 0.03 | Why? |
| Leukocytes | 1 | 2017 | 1046 | 0.03 | Why? |
| Glycated Hemoglobin A | 1 | 2018 | 1316 | 0.03 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.03 | Why? |
| Apoptosis | 1 | 2020 | 2335 | 0.03 | Why? |
| Medical Staff, Hospital | 1 | 2020 | 1258 | 0.03 | Why? |
| Antibiotic Prophylaxis | 1 | 2013 | 399 | 0.02 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.02 | Why? |
| Insulin Resistance | 1 | 2015 | 669 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2019 | 3776 | 0.02 | Why? |
| Hospital Units | 1 | 2017 | 1017 | 0.02 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 7868 | 0.02 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.02 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.02 | Why? |
| Macrophages | 1 | 2021 | 2784 | 0.02 | Why? |
| Mice | 2 | 2019 | 21357 | 0.02 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.02 | Why? |
| Immunity | 1 | 2020 | 2651 | 0.02 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.02 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Health Facilities | 1 | 2017 | 1230 | 0.02 | Why? |
| Molecular Targeted Therapy | 1 | 2017 | 1579 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Congresses as Topic | 1 | 2018 | 1347 | 0.02 | Why? |
| Endothelial Cells | 1 | 2018 | 2048 | 0.02 | Why? |
| Endoscopy, Gastrointestinal | 1 | 2019 | 1545 | 0.02 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.02 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.02 | Why? |
| Electronic Health Records | 1 | 2020 | 3492 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.02 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.02 | Why? |
| Epithelial Cells | 1 | 2019 | 3508 | 0.02 | Why? |
| Quality Improvement | 1 | 2019 | 2435 | 0.02 | Why? |
| Kluyveromyces | 1 | 2005 | 7 | 0.02 | Why? |
| Employment | 1 | 2017 | 1754 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.02 | Why? |
| World Health Organization | 1 | 2018 | 4213 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.02 | Why? |
| Serine Endopeptidases | 1 | 2020 | 4606 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| RNA, Messenger | 1 | 2018 | 5131 | 0.02 | Why? |
| Logistic Models | 1 | 2019 | 9089 | 0.02 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.02 | Why? |
| Depression | 2 | 2018 | 14116 | 0.02 | Why? |
| Milk | 1 | 2005 | 158 | 0.02 | Why? |
| Symptom Assessment | 1 | 2018 | 4967 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Skin Neoplasms | 1 | 2017 | 1679 | 0.02 | Why? |
| Clinical Competence | 1 | 2018 | 3263 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.02 | Why? |
| Patient Discharge | 1 | 2019 | 5696 | 0.02 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 1573 | 0.01 | Why? |
| Internet | 1 | 2020 | 6204 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Education, Medical | 1 | 2018 | 2461 | 0.01 | Why? |
| Immunoglobulin M | 1 | 2019 | 9091 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Anticoagulants | 1 | 2021 | 9563 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2019 | 7330 | 0.01 | Why? |
| Patient Safety | 1 | 2013 | 4885 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| Gastroscopy | 1 | 1998 | 112 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Registries | 1 | 2017 | 12327 | 0.01 | Why? |
| Adrenal Cortex Hormones | 1 | 2013 | 6537 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Health Services Accessibility | 1 | 2019 | 10697 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2019 | 21571 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Drug Administration Schedule | 1 | 1998 | 2324 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |